NCT07166068

Brief Summary

This study is designed to investigate whether a hands-on therapy called Mobilization with Movement (MWM) can reduce pain and inflammation in individuals with knee osteoarthritis (OA). The investigators will compare MWM to a sham treatment that resembles mobilization but does not involve the specific therapeutic movements. Both groups will also receive standard care, including exercise and education about managing knee OA. A total of 40 adults (aged 18 years and older) with moderate to severe knee OA will be enrolled. Participants will be randomly assigned to either the MWM group or the sham group. Each intervention will be delivered twice per week over a four-week period. Outcomes will include measures of inflammation obtained from blood samples, self-reported pain levels, and assessments of knee function before and after the intervention period. It is hypothesized that individuals allocated to the MWM group will demonstrate reduced inflammation and pain compared with those in the sham group. The findings of this study may help clarify the potential role of MWM as a treatment option for knee OA.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2024

Completed
10 months until next milestone

First Posted

Study publicly available on registry

September 10, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

September 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2026

Completed
Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

November 28, 2024

Last Update Submit

December 8, 2025

Conditions

Keywords

Knee OAMWMManual TherapyCRPESR

Outcome Measures

Primary Outcomes (2)

  • C-Reactive Protein (CRP)

    CRP levels will be measured in unit of measure (mg/L) using a high-sensitivity assay.

    Baseline and 4 weeks post-intervention.

  • Erythrocyte Sedimentation Rate (ESR)

    ESR will be measured in mm/hr using the Westergren method.

    Baseline and 4 weeks post-intervention.

Secondary Outcomes (2)

  • Pain Intensity

    The outcome measure will be assessed at the baseline and 4 weeks post-intervention.

  • Functional Status

    The outcome measure will be assessed at the baseline and 4 weeks post-intervention.

Study Arms (2)

Intervention Group

EXPERIMENTAL

The intervention group will receive mobilization with movement for the affected knee with standard care (exercise program to strengthen the musculature of the knee).

Other: Manual Therapy (Mobilization with Movement)Other: Exercise

Control Group

PLACEBO COMPARATOR

The control group will receive sham mobilization with movement for the affected knee with standard care (exercise program to strengthen the musculature of the knee).

Other: ExerciseOther: sham mobilization

Interventions

standard care (exercise program to strengthen the musculature of the knee)

Control GroupIntervention Group

The therapist will simulate MWM by performing slight external rotation of the skin only. This mimics the tactile sensation of true MWM without affecting the underlying joint mechanics.

Control Group

A continuous glide to the tibia will be a combined simultaneously by whether medial, lateral, anterior, posterior, or rotational-during active knee flexion and extension repeated movement as applied by Mulligan.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of unilateral or bilateral knee osteoarthritis (OA) according to the criteria of the American College of Rheumatology
  • Age ≥ 18 years
  • Kellgren-Lawrence grade 2 or 3 knee OA
  • Pain intensity \> 3 on a visual analogue scale (VAS)
  • Body mass index (BMI) between 18.5 and 30 kg/m²

You may not qualify if:

  • Knee or lower limb surgery within the last six months.
  • Significant joint disorders (e.g., rheumatoid arthritis, gout, or other inflammatory arthritis).
  • Recent significant acute infections.
  • Contraindications to mobilization with movement.
  • Current or recent use systemic glucocorticoids, intra-articular glucocorticoid injections or intra-articular hyaluronic acid injections.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jazan University Hospital

Jizan, Jazan Region, 82722, Saudi Arabia

RECRUITING

Related Publications (6)

  • Li LL, Hu XJ, Di YH, Jiao W. Effectiveness of Maitland and Mulligan mobilization methods for adults with knee osteoarthritis: A systematic review and meta-analysis. World J Clin Cases. 2022 Jan 21;10(3):954-965. doi: 10.12998/wjcc.v10.i3.954.

    PMID: 35127909BACKGROUND
  • Shabbir M, Gul I, Asghar E, Muhammad N, Mehjabeen H, Rafiq I, Arshad N. Effectiveness Of Maitland's Mobilization And Conventional Physical Therapy On Synovial Biomarkers In Patients With Knee Osteoarthritis; A Randomized Control Trial. Webology. 2022 Apr 1;19(2)

    BACKGROUND
  • Hanada M, Takahashi M, Furuhashi H, Koyama H, Matsuyama Y. Elevated erythrocyte sedimentation rate and high-sensitivity C-reactive protein in osteoarthritis of the knee: relationship with clinical findings and radiographic severity. Ann Clin Biochem. 2016 Sep;53(Pt 5):548-53. doi: 10.1177/0004563215610142. Epub 2015 Sep 17.

    PMID: 26384360BACKGROUND
  • Zaki NA, Saleem TH, Said E, Hassan MH. Evidence of contributory role of inflammation in patients with knee osteoarthritis. SVU-International Journal of Medical Sciences. 2020 Jan 1;3(1):1-6.

    BACKGROUND
  • Althomali OW, Amin J, Acar T, Shahanawaz S, Talal Abdulrahman A, Alnagar DK, Almeshari M, Alzamil Y, Althomali K, Alshoweir N, Althomali O, Aldhahi MI, Bin Sheeha BH. Prevalence of Symptomatic Knee Osteoarthritis in Saudi Arabia and Associated Modifiable and Non-Modifiable Risk Factors: A Population-Based Cross-Sectional Study. Healthcare (Basel). 2023 Mar 2;11(5):728. doi: 10.3390/healthcare11050728.

    PMID: 36900733BACKGROUND
  • Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020 Nov 26;29-30:100587. doi: 10.1016/j.eclinm.2020.100587. eCollection 2020 Dec.

    PMID: 34505846BACKGROUND

Related Links

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Musculoskeletal ManipulationsMovementExercise

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitationPhysiological PhenomenaMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaMotor Activity

Central Study Contacts

Abdulraouf Ayoub, PT

CONTACT

Mohammed Moslem, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
While participants and outcome assessors are blinded to treatment allocation, therapists delivering the MWM and sham mobilization interventions are aware of the assigned treatment for each participant. However, therapists are blinded to all outcome measures, including pain scores, inflammatory marker results, and functional assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Department of Physical Therapy, Principal Investigator

Study Record Dates

First Submitted

November 28, 2024

First Posted

September 10, 2025

Study Start

September 20, 2025

Primary Completion

February 20, 2026

Study Completion

April 20, 2026

Last Updated

December 9, 2025

Record last verified: 2025-12

Locations